Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours
Histopathology · 2025
DOI: 10.1111/his.15385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Gregor Krings und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Aims
Unusual morphologic patterns of breast carcinomas can raise diagnostic consideration for metastasis or special breast cancer subtypes with management implications. We describe rare invasive breast cancers that mimic serous carcinoma of the gynaecologic tract (serous‐like breast carcinomas, SLBC) and characterize their clinicopathologic, immunophenotypic, and genetic features. Methods and Results All patients were female ( n = 15, median age 49 years) without a history of gynaecologic malignancy. SLBC were characterized histologically by angulated, branched, sometimes anastomosing glands with micropapillary and/or pseudopapillary luminal projections in desmoplastic stroma. Most SLBC were triple‐negative (TN, n = 10) or HER2‐positive ( n = 2) and grade 2 or 3, while some were oestrogen receptor (ER) low‐positive/HER2‐negative and low‐grade ( n = 3). CK5/6 was positive irrespective of grade or receptor status (10/10). All SLBC expressed GATA3 (14/15), TRPS1 (7/7), and/or mammaglobin (4/13). SOX10 was positive in most TN (9/10) and all ER low‐positive (3/3) cases, but negative in HER2‐positive tumours. WT1 was universally negative, and PAX8 was focal in one mammaglobin‐positive tumour. All ER‐negative SLBC were p53‐aberrant and 9/11 were p16‐aberrant, whereas ER‐positive tumours were wildtype for both markers (3/3). TP53 was the only frequently mutated gene, altered in all ER‐negative (10/10) but no ER‐positive (0/4) tumours. Clinical behaviour was variable. Only 1/6 patients achieved pathologic complete response to neoadjuvant chemotherapy.
Conclusion
SLBC is a rare morphologic pattern of invasive breast carcinoma that mimics metastatic serous gynaecologic carcinoma, a potential diagnostic pitfall. SLBC are heterogeneous with respect to grade, receptor profile, and oncogenic driver alterations, without specific genetic underpinnings identified. Additional studies are warranted to further evaluate the clinical behaviour of these tumours.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of California San Francisco, San Francisco, California, USA.
- Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Pathology, Centre Henri Becquerel, Rouen, France.
- Department of Pathology, Stanford University, Stanford, California, USA.
- Department of Pathology, University of Colorado, Aurora, Colorado, USA.
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
ORCID-Profile: Gregor Krings, Eliah R Shamir, Marick Laé, Gregory R Bean, Miriam D Post, Yunn-Yi Chen
Zitieren
APA
Krings, G., Shamir, E. R., Laé, M., Bean, G. R., Post, M. D., Schnitt, S. J., & Chen, Y. Y. (2025). Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours. Histopathology. https://doi.org/10.1111/his.15385
Vancouver
Krings G, Shamir ER, Laé M, Bean GR, Post MD, Schnitt SJ, et al. Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours. Histopathology. 2025. doi:10.1111/his.15385
BibTeX
@article{Krings2025,
author = {Krings, Gregor and Shamir, Eliah R and Laé, Marick and Bean, Gregory R and Post, Miriam D and Schnitt, Stuart J and Chen, Yunn-Yi},
title = {Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours},
journal = {Histopathology},
year = {2025},
doi = {10.1111/his.15385}
}
EUVIMED